Current Management of Carcinoid Tumor: When Is a Wedge Enough?
Publication/Presentation Date
5-1-2023
Abstract
Bronchopulmonary carcinoid tumors are rare, well-differentiated neuroendocrine neoplasms. They can be categorized as typical or atypical lesions and are low-to-intermediate-grade, respectively. The cornerstone of therapy for carcinoid tumors is surgical resection and current consensus guidelines recommend anatomic resection for stage I to IIIA disease. The renewed interest in sublobar resections for the treatment of lung malignancies has sparked debate over the degree of resection necessary for these indolent lesions. Segmentectomy provides an oncologic resection while preserving as much lung parenchyma as possible, and is a reasonable approach to apply to small, undifferentiated, or typical carcinoid lesions.
Volume
33
Issue
2
First Page
159
Last Page
164
ISSN
1558-5069
Published In/Presented At
Collins, M. L., & Okusanya, O. (2023). Current Management of Carcinoid Tumor: When Is a Wedge Enough?. Thoracic surgery clinics, 33(2), 159–164. https://doi.org/10.1016/j.thorsurg.2023.01.008
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
37045485
Department(s)
Administration and Leadership
Document Type
Article